Macroeconomic News
The quality and completeness of news and information about current macroeconomic events and trends
Cat avg: 7.5
The quality and completeness of news and information about current macroeconomic events and trends
Cat avg: 7.5
The quality and completeness of industry-specific information, e.g., the progress or success of clinical trials in the pharmaceutical industry
Cat avg: 7.4
The quality and completeness of mergers and acquisitions filings, news, rumors, etc.
Cat avg: 5.8
The quality and effectiveness of tools to help locate specific and relevant information within the platform
Cat avg: 8.3
The ability to access fundamentals, earnings, or other information for companies that are not publicly listed
Cat avg: 5.3
The ability to access third-party analyses, e.g., Morningstar reports
Cat avg: 8.3
The most important features for the effectiveness of a financial research platform
The ability to access fundamentals, earnings, or other information for companies that are not publicly listed
Category average: 5.3
The quality and completeness of industry-specific information, e.g., the progress or success of clinical trials in the pharmaceutical industry
Category average: 7.4
The ability to access third-party analyses, e.g., Morningstar reports
Category average: 8.3
The quality and completeness of mergers and acquisitions filings, news, rumors, etc.
Category average: 5.8
The quality and completeness of news and information about current macroeconomic events and trends
Category average: 7.5
The quality and effectiveness of tools to help locate specific and relevant information within the platform
Category average: 8.3
The ability to access fundamentals, earnings, or other information through company filings and other sources
The ability to access fundamentals, earnings, or other information for companies that are not publicly listed
The quality and completeness of analyses and research on the overall performance and outlook of specific sectors and industries
The quality and completeness of industry-specific information, e.g., the progress or success of clinical trials in the pharmaceutical industry
The ability to access third-party analyses, e.g., Morningstar reports
The quality and completeness of mergers and acquisitions filings, news, rumors, etc.
The quality and completeness of information on how a company sources its materials and other production resources
The quality and completeness of data on Environmental, Social, and Governance practices
The quality and completeness of information on corporate credit ratings
The quality and completeness of news and information about current macroeconomic events and trends
The quality and effectiveness of tools to help locate specific and relevant information within the platform